Publication
A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
Richard A. Brigandi, Richard A. Brigandi, Brendan Johnson, Brendan Johnson, Coreen Oei, Coreen Oei, Mark Westerman, Mark Westerman, Gordana Olbina, Gordana Olbina, Janak de Zoysa, Janak de Zoysa, Simon D. Roger, Simon D. Roger, Manisha Sahay, Manisha Sahay, Nicholas Cross, Nicholas Cross, Lawrence McMahon, Lawrence McMahon, Veerabhadra Guptha, Veerabhadra Guptha, Elena A. Smolyarchuk, Elena A. Smolyarchuk, Narinder Singh, Narinder Singh, Steven F. Russ, Steven F. Russ, Sanjay Kumar, Sanjay Kumar, Alexey V. Borsukov, Alexey V. Borsukov, Vyacheslav V. Marasaev, Vyacheslav V. Marasaev, Gullipalli Prasad, Gullipalli Prasad, Galina Y. Timokhovskaya, Galina Y. Timokhovskaya, Elena V. Kolmakova, Elena V. Kolmakova, Vladimir A. Dobronravov, Vladimir A. Dobronravov, Elena V. Zakharova, Elena V. Zakharova, Georgi Abraham, Georgi Abraham, David Packham, David Packham, Dmitry A. Zateyshchikov, Dmitry A. Zateyshchikov, Gregory P. Arutyunov, Gregory P. Arutyunov, Galina V. Volgina, Galina V. Volgina, Kirill S. Lipatov, Kirill S. Lipatov, Dmitry V. Perlin, Dmitry V. Perlin, Bruce Cooper, Bruce Cooper, Tarun Kumar Saha, Tarun Kumar Saha, Olga A. Zagrebelnaya, Olga A. Zagrebelnaya, Kalpana S. Mehta, Kalpana S. Mehta, Natalya A. Koziolova, Natalya A. Koziolova, Rob Fassett, Rob Fassett, Narina P. Alexeeva, Narina P. Alexeeva, Lidia V. Lysenko, Lidia V. Lysenko
American Journal of Kidney Diseases, June 2016, Elsevier
DOI: 10.1053/j.ajkd.2015.11.021
